Collaboration - July 29, 2025
Neuraxpharm and Dizlin Pharmaceuticals enter co-development agreement
Neuraxpharm Group and Swedish Dizlin Pharmaceuticals have announced a strategic global co-development agreement for Infudopa SubC.
Collaboration - July 28, 2025
FluoGuide enters collaboration with Olympus
The objective of the collaboration is to develop FG001 for tumor imaging and surgical margins assessment for head and neck cancer.
Collaboration - July 16, 2025
EUR 80 million investment in new Nordic quantum initiative
EIFO, the export and investment fund of Denmark, and the Novo Nordisk Foundation are investing in the establishment of QuNorth, with the purpose to advance the region’s technological development.
Collaboration - June 25, 2025
Oxcia enters a research collaboration with LEO Pharma
The two companies will explore OXC-101 in topical formulations for medical dermatology indications including psoriasis.
Collaboration - June 13, 2025
Salipro Biotech enters collaboration agreement with Daewoong Pharmaceutical
The collaboration combines Salipro Biotech's expertise and its Salipro platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs.
CDMO - June 9, 2025
ReciBioPharm expand collaboration with University of Oxford
The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division are expanding their collaboration with the development of two blood-stage malaria vaccine candidates for Phase 1/2 clinical trials.
